Tempus Technology

AI-enabled clinical assistant that provides access to patient insights directly at your fingertips.

• Retrieve patient information

  Quickly access patient information, like report status, results on actionable biomarkers, and MSI/TMB status.

• Filter patients by alterations, genes, or diagnoses

  View relevant cohorts of your patients for additional insights that may support you in patient treatment decisions.

• Identify relevant, up-to-date clinical trials

  Discover the latest clinical trials based on specific patient enrollment criteria so your patients can receive care quickly.

Suite of applications that live inside EHRs.

• Seamless EHR ordering and result delivery

  Place orders and receive results, directly in your EHR.

• Unlock structured genomic data

  Discrete genomic data can power your EHR’s decision-making, advanced analytics, and clinical research.

• Refresh therapies and clinical trials

  Refresh therapies and clinical trials available for your patients based on previous test results – all inside your EHR.

A central platform for researchers and scientists to find, access, and analyze Tempus data.

• Define cohorts of interest

  Apply Inclusion and Exclusion criteria to generate cohorts of interest using our AI assistant.

• Refine and visualize

  Gain insight from quick no-code analyses with Lens Analytical Apps.

• Analyze to uncover critical insights

  Leverage RWD in a flexible computational environment with Lens Workspaces, using R and Jupyter Notebooks.

AI-enabled insights from medical images.

• Automated quantification

  Segments and measures lesions of interest, providing accurate contours and long-axis and short-axis measurements.

• Automated tracking

  Links lesions across time points to create longitudinal tracking reports to calculate lesion response automatically.

• Automated reporting

  Automates therapy response criteria and generates a comprehensive report that can be linked to the patient record in the EMR or Tempus Hub.

Identify and close gaps in care.

• Patient identification

  Identifies patients and contextualizes where they are in the care journey relative to clinical guidelines.

• Notifications in workflow

  Uses tiered and customized notifications driven by physician preferences.

• Tracking across the care continuum

  Tracking for patients who need timely management, lists to search for subsets of patients, and dashboards for real-time insights into a hospital’s patient population.

Our genomic profiling services encompass a broad range of sequencing options, allowing for data-driven patient decisions.

• xT: 648 gene DNA sequencing panel (includes heme malignancies).
• xR: Whole-transcriptome RNA sequencing panel (includes heme malignancies).
• xF/xF+: 105/523 ctDNA sequencing panel.
• xG/xG+: 52/88 gene panel for hereditary cancers.
• xE: Whole exome, 19,000+ gene DNA sequencing panel.

Gain additional insights across multiple cancer types through our algorithmic testing options.

• HRD: Measures homologous recombination deficiency.
• TO: Refines diagnosis for cancers with uncertain origins.
• DPYD: Identifies patients at elevated risk for toxicity to 5 FU and/or capecitabine.
• UGT1A1: Identifies patients at elevated risk for toxicity to irinotecan, sacituzumab govitecan, and/or belinostat.
• PurIST℠: Classifies pancreatic ductal adenocarcinomas into one of two subtypes (basal-like or classical).